Novartis AG is 203.2x more valuable than ARDELYX, INC. by market capitalization ($283.13 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARDX | NVS |
|---|---|---|
| Market cap | $1.39 B | $283.13 B |
| US-listed rank | #2387 | #47 |
| Revenue (latest FY) | $407.32M | - |
| Net income (latest FY) | -$62.00M | - |
| Net margin | -15.2% | - |
| SEC filings | 1,143 | 947 |
Novartis AG is 203.2x more valuable than ARDELYX, INC. by market capitalization ($283.13 B vs $1.39 B).
Full pages: ARDELYX, INC. and Novartis AG, or browse the full rankings.